Literature DB >> 12657997

Effects of magnesium administration on brain edema and blood-brain barrier breakdown after experimental traumatic brain injury in rats.

Figen Esen1, Tulin Erdem, Damla Aktan, Rivaze Kalayci, Nahit Cakar, Mehmet Kaya, Lutfi Telci.   

Abstract

In this study, we examined the effects of magnesium sulfate administration on brain edema and blood-brain barrier breakdown after experimental traumatic brain injury in rats. Seventy-one adult male Sprague-Dawley rats were anesthetized, and experimental closed head trauma was induced by allowing a 450-g weight to fall from a 2-m height onto a metallic disk fixed to the intact skull. Sixty-eight surviving rats were randomly assigned to receive an intraperitoneal bolus of either 750 micromol/kg magnesium sulfate (group 4; n = 30) or 1 mL of saline (group 2; n = 30) 30 minutes after induction of traumatic brain injury; 39 nontraumatized animals received saline (group 1; n = 21) or magnesium sulfate (group 3; n = 18) with an identical protocol of administration. Brain water content and brain tissue specific gravity, as indicators of brain edema, were measured 24 hours after traumatic brain injury. Blood-brain barrier integrity was evaluated quantitatively 24 hours after injury by spectrophotometric assay of Evans blue dye extravasations. In the magnesium-treated injured group, brain water content was significantly reduced (left hemisphere: group 2, 83.2 +/- 0.8; group 4, 78.4 +/- 0.7 [P <.05]; right hemisphere: group 2, 83.1 +/- 0.7; group 4, 78.4 +/- 0.5. [P <.05]) and brain tissue specific gravity was significantly increased (left hemisphere: group 2, 1.0391 +/- 0.0008; group 4, 1.0437 +/- 0.001 [P <.05]; right hemisphere, group 2, 1.0384 +/- 0.001; group 4, 1.0442 +/- 0.005 [P <.05]) compared with the saline-treated injured group. Evans blue dye content in the brain tissue was significantly decreased in the magnesium-treated injured group (left hemisphere: group 2, 0.0204 +/- 0.03; group 4, 0.0013 +/- 0.0002 [P <.05]; right hemisphere: group 2, 0.0064 +/- 0.0009; group 4, 0.0013 +/- 0.0003 [P <.05]) compared with the saline-treated injured group. The findings of the present study support that beneficial effects of magnesium sulfate exist after severe traumatic brain injury in rats. These results also indicate that a blood-brain barrier permeability defect occurs after this model of diffuse traumatic brain injury, and magnesium seems to attenuate this defect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657997     DOI: 10.1097/00008506-200304000-00009

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  17 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

2.  The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  Abutaher M Yahia; Jawad F Kirmani; Adnan I Qureshi; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

4.  Magnesium Sulfate Provides Neuroprotection in Eclampsia-Like Seizure Model by Ameliorating Neuroinflammation and Brain Edema.

Authors:  Xiaolan Li; Xinjia Han; Jinying Yang; Junjie Bao; Xiaodan Di; Guozheng Zhang; Huishu Liu
Journal:  Mol Neurobiol       Date:  2016-11-22       Impact factor: 5.590

5.  Magnesium sulfate protects blood-brain barrier integrity and reduces brain edema after acute ischemic stroke in rats.

Authors:  Javad Shadman; Nooshin Sadeghian; Alireza Moradi; Shahab Bohlooli; Hamdollah Panahpour
Journal:  Metab Brain Dis       Date:  2019-04-29       Impact factor: 3.584

Review 6.  Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

Authors:  Niklas Marklund; Lars Hillered
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

7.  High dose magnesium infusions are not associated with increased pressor requirements after carotid endarterectomy.

Authors:  Camay Chiu; Eric J Heyer; Anita D Rampersad; Joseph Zurica; Eugene Ornstein; Daniel H Sahlein; Robert R Sciacca; E Sander Connolly
Journal:  Neurosurgery       Date:  2006-01       Impact factor: 4.654

Review 8.  Magnesium sulfate for the treatment of eclampsia: a brief review.

Authors:  Anna G Euser; Marilyn J Cipolla
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

9.  Cerebrovascular dysfunction and blood-brain barrier permeability induced by oxidized LDL are prevented by apocynin and magnesium sulfate in female rats.

Authors:  Malou P H Schreurs; Marilyn J Cipolla
Journal:  J Cardiovasc Pharmacol       Date:  2014-01       Impact factor: 3.105

10.  Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study.

Authors:  Figen Esen; Tulin Erdem; Damla Aktan; Mukadder Orhan; Mehmet Kaya; Haluk Eraksoy; Nahit Cakar; Lutfi Telci
Journal:  Crit Care       Date:  2004-11-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.